Acute Myeloid Leukemia Research Today is a free monthly online journal that collates and summarizes the latest research about Acute Myeloid Leukemia, including details on aml, symptoms, treatment, information.

Volume 4 (2007), Issue 3 (March)

1. Minimally differentiated acute myeloid leukemia (FAB AML-M0) is associated with an adverse outcome in children: a report from the Children's Oncology Group, studies CCG-2891 and CCG-2961.
   Blood, 109(6): 2314-21. [Abstract] [Full-text]
2. Flt3 Y591 duplication and Bcl-2 overexpression are detected in acute myeloid leukemia cells with high levels of phosphorylated wild-type p53.
   Blood, 109(6): 2589-96. [Abstract] [Full-text]
3. Neutrophilic eccrine hidradenitis masquerading as facial cellulitis.
   J Am Acad Dermatol, 56(4): 693-6. [Abstract] [Full-text]
4. Evaluation of the L-stereoisomeric nucleoside analog troxacitabine for the treatment of acute myeloid leukemia.
   Expert Opin Investig Drugs, 16(4): 547-57. [Abstract] [Full-text]
5. T cells remaining after intensive chemotherapy for acute myelogenous leukemia show a broad cytokine release profile including high levels of interferon-gamma that can be further increased by a novel protein kinase C agonist PEP005.
   Cancer Immunol Immunother, 56(6): 913-25. [Abstract] [Full-text]

© 2004-2012 Acute Myeloid Leukemia Research Today. All Rights Reserved.